objective The objective of this study was to describe the factors associated with the development of Guillain-Barr e syndrome, both infectious and non-infectious, during and after the A(H1N1) influenza pandemic in 2009 and the recent Zika virus epidemic in the Americas.
Introduction
Guillain-Barr e syndrome (GBS) is an acute inflammatory demyelinating polyradiculoneuropathy that is autoimmune in nature. It has an acute or subacute beginning and is characterised by diversified levels of limb weakness or muscles with cranial nerve innervation, loss or diminished deep tendon reflexes and albuminocytologic dissociation [1, 2] . It is normally triggered by an acute infectious process and is a leading cause of flaccid paralysis in the world [3, 4] . The precise cause of the syndrome is not known, but 50-70% of the cases occur a week or two after a gastrointestinal or a respiratory infection or other immune stimulus that triggers an atypical autoimmune response that affects the peripheral nerves and their spinal roots [5] .
The classification of GBS subtypes depends on the nerve fibre affected -sensory, motor or autonomic -and the prominent condition of the peripheral nerve or nerve root damage. Inflammatory demyelinating polyradiculoneuropathy (AIDP) is the most common variant of GBS associated with the destruction of the myelin sheath in peripheral nerves and roots. In North America, Australia and Europe, it is estimated to be present in 90-95% of all GBS cases [1, 6, 7] . Acute motor axonal neuropathy (AMAN) is the motor form of the syndrome, has no sensory involvement and occurs as a result of damage in the nodes of Ranvier. It is mostly associated with Campylobacter jejuni infection and is common in China, Japan and Mexico. Acute motor and sensory axonal neuropathy (AMSAN) affects both the motor and sensory nerves [3, 7, 8] .
Guillain-Barr e syndrome has a global annual incidence of 0.5-2 cases per 100 000 persons-years and the incidence increases with age, 2.7 cases per 100 000 person-year among people over 80 years and over [2, 9, 10] . It is rare in children with <2 years of age, 0.6 per 100 000 children [5, 10] . Between 1995 and 2002, the estimated annual incidence in Brazil was 0.6 per 100 000 people [11] . Men are more susceptible to GBS than women with a ratio of 1.1:1-2:1, but there is no plausible cause of the preponderance in frequency of male patients [2, 12] .
Many infectious and non-infectious aetiological agents are known to trigger GBS. Campylobacter jejuni infection is mostly associated with the occurrence of the syndrome with a frequency of 25-50% among adults with GBS and is common in Asian countries. Other infectious causes of GBS are cytomegalovirus, Epstein-Barr virus, measles, influenza A virus, Mycoplasma pneumonia, enterovirus D68 and Zika virus (ZIKV) [5] .The first cases of GBS associated with ZIKV infection were reported in French Polynesia in a ZIKV outbreak between October 2013 and April 2014 [13] . In Brazil, the first Zika cases were reported in the northeast of the country in 2015 [14] .
Non-infectious agents such as vaccines and surgery have been reported to trigger GBS. The first cases of the syndrome associated with vaccines were reported in New Jersey in the United States after swine flu vaccination in 1976-1977. The estimated relative risk was 7.6 (95% CI: 6.7-8.6) showing causality between the vaccine and GBS in the first 6 weeks of the vaccination campaign. Since then, many studies have been published addressing association between GBS and vaccines, but most of them have insufficient evidence or show no risk of developing GBS after the administration of influenza vaccine or other vaccines [15] [16] [17] . Cases of GBS after surgery are also known to occur, but the development of the syndrome associated with this factor is not yet known [3] .
During the period of study, two epidemics of infections occurred which have been linked with the development of Guillain-Barr e syndrome. In 2009, the pandemic H1N1 affected most parts of the world, and in 2015, there was a ZIKV epidemic in the Americas that later spread to other parts of the world. After the 1976 swine influenza vaccination that resulted in an increased risk of developing GBS in the United States weeks after its administration, it became a public concern during the pandemic influenza vaccination in 2009. A study conducted in the USA using various surveillance systems found an increased risk of GBS equivalent to 1.6 excess cases of the syndrome per million people vaccinated [18] . Causality was also confirmed in another study that evaluated neurological adverse events after the 2009 H1N1 vaccination. GBS cases were predominant in this study [19] .
In relation to GBS and ZIKV infection, studies have also shown plausible evidence of causality [13, 20] .The increase in the number of GBS cases in Brazil and other regions of the world that had epidemics of ZIKV prompted the urge to analyse epidemiological publications addressing the aetiology of GBS before, during and after the ZIKV epidemic.
The study designs considered in this systematic review comprise cohorts, case controls and studies with self-controlled case series and self-controlled risk interval designs. Cohort studies are ideal for studying causality, multiple exposures and also rare exposures [21] . Case-control studies are useful in studying aetiology of diseases, and unlike cohort studies, they require a short execution period, are cheap and can be used to study rare diseases [22, 23] . Self-controlled case series studies (SCCS) investigate the association between a rare exposure to a risk factor and a consequent outcome and have a predefined risk period. They are an alternative to cohort and case-control studies in studying association between an exposure that varies over time and its outcome. The cases serve as controls [24] [25] [26] . Self-controlled risk interval designs are similar to SCCS; however, each case has two control periods, before and after an exposure to a risk factor [27] .
The aim of this study was to describe the factors associated with the development of the GBS, both infectious and non-infectious, through a systematic review of scientific literature and to describe the publications identified before, during and after the A(H1N1) influenza pandemic in 2009 and the recent ZIKV epidemic in the Americas. This is the first systematic review to our knowledge that has synthesised various factors associated with the development of GBS.
Materials and methods
This systematic review was conducted in accordance with a study protocol previously elaborated and was registered in International Prospective Register of Systematic Reviews (PROSPERO) under registry number: CRD42017077212. The study is reported according to the Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) [28] .
Study identification
The databases used were Medical Literature Analysis and Retrieval System Online (MEDLINE), EBSCOhost Research Databases (EBSCO) and Latin American and Caribbean Literature in Health Sciences (LILACS). No studies were identified in the manual search of the grey literature. The search strategy combined subject headings of Medical Subject Headings (MESH) and other terms as presented in the Box S1.
Study selection
The PICOS/PECOS (population, intervention/exposure, comparison, outcome, study design) model guided the definition of the research question and the identification of the eligibility criteria and the research question was: What are the principal infectious and non-infectious factors associated with Guillain-Barr e syndrome?
Articles were included if they had been published between 1 January 2007 and 30 June 2017, were epidemiological studies with an aetiological approach with the following study designs: case-control, analytical cohort, self-controlled case series and self-controlled risk interval and were written in Portuguese, English, French or Spanish.
Data extraction
Two authors (W.K.V and P.M.H) working independently reviewed the studies and extracted data using a standardised Excel data extraction template developed specifically for this study. In the event of doubt, the third author (O.M.R) was asked to confirm or not the selection of a study. The data extracted from each study were year and country of publication, aetiological agent, the study population, study design, number of cases and controls and crude and adjusted measure of association.
Quality assessment
The quality of individual studies was assessed using the Newcastle Ottawa Scale (NOS) for cohort and case-control study designs. To assess quality of the self-controlled case series and self controlled risk interval studies, we adapted the instrument used for quality evaluation studies [29] , as shown in Appendix S1.
Results
Of 224 articles identified by searching the databases, 34 articles met the proposed criteria and were included the qualitative synthesis of this systematic review ( Figure 1 ).
In the 10-year period of study, most articles were published in 2013, followed by 2011 and 2014 with six and five publications each respectively ( Figure 2 ). Most articles in these years studied the association of GuillainBarr e syndrome and pandemic influenza vaccines and also the seasonal influenza vaccines.
The WHO regionalisation criteria were used to analyse the geographical distribution of the region of publication of the articles. The American region was analysed separately. A majority of the studies (41.2% 14/34) were performed in the European region, (26.5% 9/34) in North America, (14.7% 5/34) in West Pacific, (8.8% 3/34) in South East Asia, (5.9% 2/34) in Eastern Mediterranean and (2.9% 1/34) in South America. No study conducted in Brazil was identified within the period of study.
In relation to the study designs, the most common was case-control (50% 17/34), cohort (23.5% 8/34), self-controlled case series (14.7% 5/34), the least common was self-controlled risk interval with (5.8% 2/34) and multiple designs (5.8% 2/34). Stars were allocated if a study was in accordance with the criteria proposed by the quality assessment instrument.
The case definition of GBS used was stated in 21/34 (62%) of the studies and 11/21 (52%) used the Brighton Criteria while 6/21 (29%) used Asbury and Cornblath definition.
A total of 19 studies with a case-control design were evaluated using the NOS instrument. In the selection category, 17/19 (89%) of the studies did not indicate whether the outcome of interest was present or not at the start of the study. Although the studies focus on new cases in the period of study, the instrument requires an indication that the controls did not have the outcome of interest and among the cases, if the outcome was occurring for the first time. In the item that describes the selection criteria of the control group, only 10/19 (53%) studies had the controls selected in the same community as the cases. In the comparability category, 6/19 (32%) of the studies did not control for confounding factors. In relation to the exposure category, the third item that evaluated the non-response rate was not met by 15/19 (79%) of the studies (Table S1 ).
A total of eight studies with a cohort design were evaluated. In the selection category, all studies met the required criteria except for the last item, where only one study stated the absence of the outcome of interest at the start of the study, in both the study and the control groups. In the comparability category, seven studies controlled for more than one confounding factor. The outcome category was well evaluated in all the studies (Table S2) .
Nine studies with self-controlled case series and selfcontrolled risk interval designs were assessed. In the selection category, none of the studies met the third item related to the absence of the outcome of interest at the beginning of the study. In the comparability section, confounding factors that vary over time were considered, but only 5/9 (56%) of the studies controlled for one of these confounding factors. In the outcome section, only 5/9 (56%) of the studies met the fourth criteria that required the follow-up period to be adequate for the outcome of interest to occur (Table S3 ). The follow-up period was considered as adequate if it was up to 42 days which is a generally accepted as the risk interval between exposure to an antigenic stimulus, in this case study, vaccinations and the development of GBS [16] .
The studies included in the systematic review addressed the association of GBS with many aetiological agents like bacteria, virus, infections, vaccines and surgery as shown in (Table 1 ). The aetiological agent mostly reported in the studies was influenza vaccine and a majority of the studies were published in 2011, 2013 and 2014. Tables  S4-S6 show the main characteristics of the studies analysed in this systematic review.
One study evaluated the association between ZIKV infection and the development of Guillain-Barr e syndrome. It was performed in French Polynesia, with a good quality assessment of six stars, showed statistical significance [Odds Ratio (OR) = 59.7, Confidence Interval (CI) 95% 10.4-+∞], and included 42 cases and 98 controls [13] . The French Polynesian study also evaluated the association between dengue virus and the development of GBS among the same cases as controls as in the ZIKV infection study, but no statistical significance was found (OR = 2.0 CI 95% 0.4-19.9) [13] . Pandemic influenza vaccine was statistically associated with the development of GBS in three of the 15 articles that studied this association. A cohort study done in Finland evaluated the association between H1N1 vaccine (Pandemrix) 6 weeks after being administered and the development of GBS among 69 exposed individuals and 380 000 controls and found an association between the specified vaccine and the syndrome [Risk Relative (RR) = 2.85 CI 95% 1.27-6.38] [30] . The study had six stars in the quality assessment. A case-control study done in Denmark, France, the Netherlands, Switzerland and the United Kingdom, with seven stars in the quality assessment, evaluated the two influenza vaccines Pandemrix and Focetria and the development of GBS. The study had 104 cases and 1198 controls. There was a statistical association between the vaccines and GBS in the crude relative risk (RR = 2.8 CI 95% 1.3-6.0); however, when the RR was adjusted to influenza-like illness, infection of the respiratory tract and the seasonal influenza vaccines, there was no association between the vaccines studied and GBS (RR = 1.0 CI 95% 0.3-2.7) [31] . In Germany, a self-controlled case series study evaluated the association between GBS and Pandemrix among 676 cases and the results were statistically significant: 19 cases of GBS occurred in the risk interval and 11 in the control period (Risk Incidence: 4.44 CI 95% 2.09-9.46) [32] . The study had eight stars in the quality assessment. The results of the studies that studied the association of H1N1 influenza vaccines are shown in Figure 3 .
Seasonal influenza vaccine was associated with the development of GBS in only one of the eight articles that studied the association of the vaccine and GBS. The study was done in Italy and had two study designs: self-controlled case series and case-control and had five stars in quality assessment. The SCCS had 176 GBS patients with 24 GBS cases occurring in the risk period and 29 in the control period while the case-control analysis included 140 cases and 308 controls. The vaccine studied had A/ H1N1, A/H3N2 subtypes and in both of the study designs, there was an association between the vaccine and the development of GBS [OR = 3.8 (1.3-10.5)/ Matched OR = 3.9 CI 95% 1.6-9.9 and RR = 2.1 CI 95% 1.1-3.9] respectively [30] . Figure 4 shows the results of the studies that evaluated the development of GBS with seasonal influenza vaccines.
Campylobacter jejuni (C. jejuni), which is one of the leading factors associated with the development of GBS, was significantly associated with the development of GBS in all seven studies that studied this association [33] [34] [35] [36] [37] . Pneumococcal vaccine, yellow fever and human papillomavirus (HPV) in girls were other vaccines reported in the studies; none were associated with the occurrence of GBS [38] [39] [40] [41] . Other aetiological agents studied that had statistically significant association with the occurrence of GBS included: M. pneumoniae (OR = 3.95 CI 95% 38, 39, [42] [43] [44] [45] . Results about influenza-like illness are shown in Figure 5 ).
Discussion
The aetiological agents studied in the articles analysed are similar to the ones found in the literature before the period of study [8, [46] [47] [48] . However, some aetiological agents such as surgery, chikungunya virus (CHIKV), ZIKV and human papillomavirus vaccine (HPV) stand out as novelties in the list of aetiological agents that trigger the development of GBS [13, 30] . ZIKV was associated with the development of GBS in only one study with good quality assessment included in the review [13] . A case-control study conducted in Colombia with 29 cases with previous probable infection with ZIKV associated with a neurological disease and 79 controls with a previous ZIKV infection and no history of neurological disease showed no statistical significance between ZIKV infection and the development of GBS. The study had six stars in the quality assessment [39] . Despite the lack of association between CHIKV and GBS in the present study, evidence from other studies with different study designs than the ones considered in this review show evidence of causality. A study done during a CHIKV outbreak in Reunion Island in 2006 found an association between CHIKV and occurrence of GBS in the absence of any other plausible factor associated with the syndrome [49] . The two studies included in the review that analysed the association of HPV vaccine and GBS did not show any increased risk of developing the syndrome among the cases compared to the controls. The study populations were women aged 18-39 years and 6-39 years [40, 41] . Similar results were found in France [50] .
Focusing on surgery, a study in Finland showed association between surgery and GBS, but the type of surgery was not specified [30] . The mechanisms that describe causality of GBS and surgery are not yet known, but there is a hypothesis that surgical procedures affect cellular and humoural immune systems that can lead to production of antimyelin antibodies. Other studies show that surgery can activate latent processes in the organism that can consequently affect the immune system [3] .
Vaccines such as pandemic influenza H1N1 and seasonal influenza vaccines and bacteria such as C. jejuni were the most reported aetiological agents in the articles analysed as shown in Tables S4-S6 . An association between the vaccines and GBS was statistically significant in three of the pandemic influenza H1N1 studies and in one of the seasonal vaccines studies [30] [31] [32] . The controversial results of the association of influenza vaccines and GBS repeat similar findings found in other studies [18, [51] [52] [53] [54] .
Campylobacter jejuni has over the years been identified as the most frequent antecedent infection in GBS since its first association with GBS in 1982. Approximately 1 in 1000 patients with the bacterial infection develops GBS [7] [8] [9] , perhaps as a result of molecular mimicry where an infectious agent triggers cross-reactive antibodies or T cells that cause the symptoms of an immune disease. Campylobacter jejuni lipo-oligosaccharide (LOS) has structural similarities to human gangliosides GM1, GM1b, GD1a and GalNAc-GD1a in peripheral nerve axons, which induces the production of anti-gangliosides antibodies IgG and IgM. The presence of these antibodies in GBS patients proves that the bacterial infection triggered the development of GBS [55] .
Case-control and cohort studies predominated among the study designs; 17 and eight articles respectively. The quality of the studies evaluated was adequate in relation to most of the items analysed which highlights low risk of bias according to the NOS instrument. Very few studies were poorly evaluated in relation to certain items of the evaluation instrument. Evaluation of the absence of the outcome of interest at the beginning of the study was poorly assessed since most of the articles did not meet this requirement. The authors may have found this detail irrelevant, but it is important to guide the reader through all methodological stages of classical epidemiological studies. In the comparability section, case-control studies, selfcontrolled case series and self-controlled risk interval study designs had a low score for failing to control for confounding factors in some studies, contrary to the requirements of the assessment tool, which could lead to comparability bias among cases and controls. The quality assessment tool used for SCCS and SCRI designs was adapted from the existing instrument for cohort studies since we found no instrument specific for these study designs. The adaptation of the cohort instrument could be limited to specific details characteristic of these study designs.
The ZIKV epidemic led to an increase in the number of cases of microcephaly and many studies were published showing association between the virus and its neurological outcomes, but focused on microcephaly and not GBS despite the increase of hospitalisations associated with GBS in the country in the same period [56] [57] [58] [59] . It is expected that more studies will be published showing factors that trigger the development of GBS not only as a consequence of ZIKV infection but also related to other aetiological factors such as dengue virus and CHIKV which circulate simultaneously with ZIKV, bacteria, vaccines such as HPV, seasonal influenza vaccines, respiratory and gastrointestinal infections. There were no national data showing causality of GBS when this study was being elaborated, despite the increase in the number of hospitalisations associated with the syndrome since ZIKV started circulating in the country in 2015 and caught the attention of the academic community, health services, community and media.
This review is the first to synthesise various factors associated with the development of GBS in a systematic review design. The period of study and the type of study designs of the studies included and their low risk of bias also contribute to the strength of the study. However, there were some limitations in the study: the case definitions used in the studies were not standardised, authors used different classification systems, and in some studies, the classification was based on professional opinion or codes in national databases that rendered the classification used questionable. The bias assessment of SCCS and SCRI study designs was based on an adapted version of the NOS instrument for cohort studies.
The discrepant results on influenza vaccines highlight the need for more studies evaluating the association of GBS and these vaccines as well as the importance of having active surveillance systems that can help in monitoring adverse effects after vaccinations. HPV vaccine was a new factor associated with the development of GBS in this study and despite the lack of causality in the studies included in this review, further studies are required to confirm or dismiss this vaccine as a trigger of GBS.
Conclusion
The ZIKV outbreak in the Americas and the consequent increase in the number of GBS cases instigated this study with the intention of detecting if the outbreak had an impact in the frequency of publications related to the aetiology of GBS during the outbreak compared to the period before and after the outbreak. Only one study in this systematic review showed causality between ZIKV and GBS, and there was no significant increase in the number of studies published. The main aetiological agents were cytomegalovirus, influenza; bacteria such as C. jejuni, M. pneumonia; vaccines like pandemic influenza H1N1 and seasonal influenza vaccines and infections, such as gastrointestinal and respiratory vaccines. 
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